Alec Stranahan
Stock Analyst at Bank of America Securities
(4.19)
# 1,472
Out of 4,355 analysts
567
Total ratings
52.2%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Alec Stranahan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Maintained: Buy | $41 → $40 | $29.40 | +36.05% | 30 | May 29, 2026 | |
| RVMD Revolution Medicines | Maintained: Buy | $185 | $157.48 | +17.48% | 33 | May 29, 2026 | |
| ERAS Erasca | Maintained: Sell | $9 | $12.84 | -29.91% | 23 | May 29, 2026 | |
| AKTS Aktis Oncology | Maintained: Buy | $34 | $20.74 | +63.93% | 7 | May 27, 2026 | |
| CGON CG Oncology | Maintained: Buy | $83 → $87 | $62.29 | +39.67% | 18 | May 26, 2026 | |
| CATX Perspective Therapeutics | Maintained: Hold | $6 | $3.94 | +52.28% | 16 | May 22, 2026 | |
| KRYS Krystal Biotech | Maintained: Buy | $364 | $309.03 | +17.79% | 29 | May 22, 2026 | |
| MRNA Moderna | Maintained: Sell | $32 | $47.19 | -32.19% | 18 | May 22, 2026 | |
| IMTX Immatics | Maintained: Buy | $17 | $11.51 | +47.70% | 16 | May 22, 2026 | |
| HCM HUTCHMED (China) | Maintained: Buy | $20 | $11.45 | +74.67% | 20 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $9 | $8.30 | +8.43% | 16 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $14 | $7.01 | +99.71% | 27 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $2.36 | +154.24% | 14 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $11.88 | +43.10% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 | $56.18 | +47.74% | 25 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $9.54 | +67.71% | 19 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $3.59 | +67.13% | 22 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $19 | $14.07 | +35.04% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $32.93 | +42.73% | 21 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.30 | +112.12% | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $21 | $14.59 | +43.93% | 21 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $3.46 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $2.16 | - | 15 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $19 | $6.58 | +188.75% | 5 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $10.97 | -27.07% | 40 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $15 | $37.94 | -60.46% | 35 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $1.17 | -14.53% | 13 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $16 | $10.65 | +50.23% | 15 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $800 → $565 | $614.78 | n/a | 3 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,150 → $1,100 | $1,105.00 | n/a | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $24.88 | n/a | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $1 | $6.20 | n/a | 4 | Dec 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $35 | $3.13 | n/a | 1 | Jan 15, 2021 |
Agios Pharmaceuticals
May 29, 2026
Maintained: Buy
Price Target: $41 → $40
Current: $29.40
Upside: +36.05%
Revolution Medicines
May 29, 2026
Maintained: Buy
Price Target: $185
Current: $157.48
Upside: +17.48%
Erasca
May 29, 2026
Maintained: Sell
Price Target: $9
Current: $12.84
Upside: -29.91%
Aktis Oncology
May 27, 2026
Maintained: Buy
Price Target: $34
Current: $20.74
Upside: +63.93%
CG Oncology
May 26, 2026
Maintained: Buy
Price Target: $83 → $87
Current: $62.29
Upside: +39.67%
Perspective Therapeutics
May 22, 2026
Maintained: Hold
Price Target: $6
Current: $3.94
Upside: +52.28%
Krystal Biotech
May 22, 2026
Maintained: Buy
Price Target: $364
Current: $309.03
Upside: +17.79%
Moderna
May 22, 2026
Maintained: Sell
Price Target: $32
Current: $47.19
Upside: -32.19%
Immatics
May 22, 2026
Maintained: Buy
Price Target: $17
Current: $11.51
Upside: +47.70%
HUTCHMED (China)
May 21, 2026
Maintained: Buy
Price Target: $20
Current: $11.45
Upside: +74.67%
May 18, 2026
Maintained: Hold
Price Target: $7 → $9
Current: $8.30
Upside: +8.43%
May 14, 2026
Reiterated: Buy
Price Target: $25 → $14
Current: $7.01
Upside: +99.71%
May 14, 2026
Maintained: Buy
Price Target: $6
Current: $2.36
Upside: +154.24%
May 13, 2026
Maintained: Hold
Price Target: $17
Current: $11.88
Upside: +43.10%
May 13, 2026
Maintained: Buy
Price Target: $83
Current: $56.18
Upside: +47.74%
May 13, 2026
Maintained: Buy
Price Target: $16
Current: $9.54
Upside: +67.71%
May 13, 2026
Maintained: Hold
Price Target: $6
Current: $3.59
Upside: +67.13%
May 12, 2026
Maintained: Hold
Price Target: $20 → $19
Current: $14.07
Upside: +35.04%
May 12, 2026
Reiterated: Buy
Price Target: $47
Current: $32.93
Upside: +42.73%
May 12, 2026
Reiterated: Buy
Price Target: $7
Current: $3.30
Upside: +112.12%
May 8, 2026
Reiterated: Buy
Price Target: $24 → $21
Current: $14.59
Upside: +43.93%
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $3.46
Upside: -
Apr 30, 2026
Maintained: Sell
Price Target: n/a
Current: $2.16
Upside: -
Apr 28, 2026
Maintained: Buy
Price Target: $21 → $19
Current: $6.58
Upside: +188.75%
Apr 8, 2026
Reiterated: Sell
Price Target: $8
Current: $10.97
Upside: -27.07%
Apr 8, 2026
Reiterated: Sell
Price Target: $15
Current: $37.94
Upside: -60.46%
Mar 27, 2026
Reiterated: Sell
Price Target: $1
Current: $1.17
Upside: -14.53%
Mar 26, 2026
Reiterated: Buy
Price Target: $14 → $16
Current: $10.65
Upside: +50.23%
Dec 10, 2024
Initiated Coverage: Sell
Price Target: $800 → $565
Current: $614.78
Upside: n/a
Nov 1, 2024
Rated: Buy
Price Target: $1,150 → $1,100
Current: $1,105.00
Upside: n/a
Aug 15, 2023
Reiterated: Buy
Price Target: $6 → $5
Current: $24.88
Upside: n/a
Dec 2, 2022
Maintained: Sell
Price Target: $10 → $1
Current: $6.20
Upside: n/a
Jan 15, 2021
Downgraded: Hold
Price Target: $35
Current: $3.13
Upside: n/a